查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1736744

乳房X光摄影系统市场（按产品类型、技术、最终用户和地区）：预测（2026-2032 年）

Mammography Systems Market By Product Type, Technology, End User, & Region for 2026-2032
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

乳房X光摄影系统市场评估（2026-2032）

乳癌发生率的上升促使人们日益意识到早期发现和筛检的重要性，从而推动了乳房X光摄影系统市场的成长。政府支持定期乳房X光摄影检查的措施和医疗政策，以及新兴国家医疗基础设施的扩张，正在推动市场成长。此外，大众对早期发现乳癌益处的认识不断提高，以及预防性保健习惯的养成，也对市场成长做出了重要贡献。预计乳房X光摄影系统市场规模将在2024年突破24.8亿美元的收益，到2032年将达到45.6亿美元。

由于旨在早期发现和改善患者预后的技术进步，乳癌市场正在经历显着成长。数位乳房乳房X光摄影已取代传统的胶片系统，提供卓越的影像品质并降低辐射剂量。 3D乳房X光摄影（也称为数位乳房断层合成）的引入实现了多层成像，增强了对緻密乳房组织异常的检测。预计2026年至2032年期间，该市场的复合年增长率将达到7.90%。

乳房X光摄影系统市场定义/概述

乳房X光摄影系统是一种用于拍摄乳房组织详细影像的诊断工具，主要用于检测乳癌。该系统使用低剂量X射线产生乳房影像，使医务人员能够识别组织中的异常或变化。该系统对于筛检和诊断都至关重要，因为早期发现乳癌可以显着改善治疗效果。

该技术已被医院、诊断中心和专科诊所广泛采用。检查过程中，乳房夹在两块板之间，X射线照射到组织中。产生的影像用于分析是否有肿瘤或其他异常征兆。该领域的进步促成了数位和3D乳房X光摄影的引入，从而提高了影像品质和准确性，尤其是在乳房组织緻密的情况下。

乳房X光摄影系统的未来预计将专注于进一步的技术进步，例如人工智慧 (AI) 和增强影像处理技术的整合。目前正在开发的 AI 演算法旨在帮助放射科医生更准确地检测早期乳癌。

技术进步和政府措施如何促进乳癌乳房X光摄影系统的需求不断增长？

数位和3D乳房X光摄影等技术进步提高了乳癌检测的准确性和效率。与传统的底片系统相比，数位乳房X光摄影可提供更高的影像品质和更少的辐射曝射量。 3D乳房X光摄影（数位乳房乳房X光摄影）的引入实现了多层成像，从而提高了对緻密乳房组织异常的检测能力。这些技术创新使乳房X光摄影系统更加有效，对医护人员和患者都更具吸引力。

政府倡议在推广定期筛检和提供指导方针以支持使用乳房X光摄影进行早期癌症检测方面发挥着重要作用。公共卫生计画通常包括提供资金和资源，以增加乳房X光摄影的可近性，尤其是在医疗资源匮乏的地区。这些政策鼓励定期筛检，提高早期发现率，并推动对先进乳房X光摄影技术的需求。

医疗保健提供者在采用新的乳房X光摄影技术时面临哪些障碍？这些挑战如何影响患者结果和系统表现？

医疗保健机构在采用新的乳房X光摄影技术时面临许多障碍。高昂的成本是一大挑战，因为像3D乳房X光摄影这样的先进乳房X光摄影系统需要大量资金来购买、安装和维护。这些高成本可能会限制这些技术的普及，尤其是在资源匮乏或偏远地区的医疗保健机构。

培训和专业知识也是重要议题。新技术通常需要对放射科医生和技术人员进行额外培训，以确保准确使用和解读结果。训练不足会导致表现不佳，影响诊断准确性。与现有系统的整合也是一个挑战。新的乳房X光摄影系统需要与现有的医疗IT基础设施相容，包括电子健康记录(EHR)和诊断影像系统。整合问题可能会妨碍无缝的工作流程和资料管理，而这对于有效的患者照护至关重要。

先进技术的引入可能会影响患者的舒适度和诊疗可及性。虽然新系统可以提供更优质的影像，但它们也可能需要更长的诊疗时间或额外的步骤，从而影响患者的舒适度和诊疗可及性。

目录

第一章全球乳房X光摄影系统市场简介

  • 市场概览
  • 分析范围
  • 先决条件

第二章执行摘要

第三章 已验证的市场研究分析方法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源列表

第四章全球乳房X光摄影系统市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 波特五力模型
  • 价值链分析

5. 全球乳房X光摄影系统市场（按技术）

  • 概述
  • 萤幕-底片乳房X光摄影
  • 数位乳房X光摄影
  • 3D乳房X光摄影

第六章全球乳房X光摄影系统市场（依产品类型）

  • 概述
  • 全视野数位化乳房乳房X光摄影
  • 模拟乳房X乳房X光摄影系统
  • 乳房断层合成系统

7. 全球乳房X光摄影系统市场（依最终用户）

  • 概述
  • 医院
  • 诊断中心
  • 专科诊所

8. 全球乳房X光摄影系统市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 其他地区 (ROW)
    • 拉丁美洲
    • 中东和非洲

第九章全球乳房X光摄影系统市场的竞争格局

  • 概述
  • 各公司市场排名
  • 主要发展策略

第十章 公司简介

  • Philips NV
  • General Electric Company
  • Analogic Corporation
  • Carestream Health Inc.
  • Fujifilm Holdings Corporation
  • Delphinus Medical Technologies
  • Hologic Inc
  • Planmed Oy
  • IMS Giotto SPA
  • Konica Minolta Inc

第十一章公司简介：附录

  • 相关分析
简介目录
Product Code: 40558

Mammography Systems Market Valuation - 2026-2032

The rising prevalence of breast cancer is increasing awareness and the need for early detection and screening, driving growth in the mammography systems market. Government initiatives and healthcare policies supporting routine mammograms, together with the expansion of healthcare infrastructure in emerging nations, have accelerated market growth. Furthermore, greater public awareness of the benefits of early breast cancer detection, as well as increased adoption of preventative healthcare practices, all contribute considerably to market growth. The mammography systems market is estimated to surpass a revenue of USD 2.48 Billion in 2024 and reach USD 4.56 Billion by 2032.

The market has experienced substantial growth, driven by technological advancements aimed at improving early breast cancer detection and patient outcomes. Digital mammography has largely replaced traditional film-based systems, offering superior image quality and reduced radiation exposure. The introduction of 3D mammography, also known as digital breast tomosynthesis, allows for multi-layered imaging, enhancing the detection of abnormalities in dense breast tissue. The market is anticipated to grow at a CAGR of 7.90% from 2026 to 2032.

Mammography Systems Market: Definition/ Overview

Mammography systems are diagnostic tools used to capture detailed images of breast tissue, primarily for the detection of breast cancer. These systems use low-dose X-rays to produce images of the breast, enabling healthcare professionals to identify abnormalities or changes in the tissue. The systems are essential in both screening and diagnostic procedures, where early detection of breast cancer significantly improves treatment outcomes.

The technology is widely employed in hospitals, diagnostic centers, and specialized clinics. During the procedure, the breast is compressed between two plates, and X-rays are passed through the tissue. The images produced are analyzed for signs of tumors or other irregularities. Advances in the field have introduced digital and 3D mammography, which offer improved image quality and accuracy, especially in dense breast tissue.

The future of mammography systems is anticipated to focus on further technological advancements, such as artificial intelligence (AI) integration and enhanced imaging techniques. AI algorithms are being developed to assist radiologists in detecting early-stage breast cancer with greater precision.

How Do Technological Advancements and Government Initiatives Contribute to the Increasing Demand for Mammography Systems in Breast Cancer Detection?

Technological advancements such as the development of digital mammography and 3D mammography have improved the accuracy and efficiency of breast cancer detection. Digital mammography offers higher image quality and lower radiation exposure compared to traditional film-based systems. The introduction of 3D mammography, or digital breast tomosynthesis, enables multi-layered imaging, which enhances the detection of abnormalities in dense breast tissue. These innovations have made mammography systems more effective and appealing for both healthcare providers and patients.

Government initiatives play a crucial role by promoting routine screening and providing guidelines that support the use of mammography for early cancer detection. Public health programs often include funding and resources to make mammography accessible, especially in underserved areas. Such policies encourage regular screenings, which increase early detection rates and drive demand for advanced mammography technologies.

What Obstacles do Healthcare Providers Encounter when Implementing New Mammography Technologies, and how do these Challenges Affect Patient Outcomes and System Performance?

Healthcare providers face several obstacles when implementing new mammography technologies, which can impact patient outcomes and system performance. High costs are a significant challenge, as advanced mammography systems, such as 3D mammography, require substantial financial investment for purchase, installation, and maintenance. This high cost can limit the availability of these technologies, particularly in underfunded or rural healthcare settings.

Training and expertise are also crucial issues. New technologies often necessitate additional training for radiologists and technicians to ensure accurate usage and interpretation of results. Insufficient training can lead to suboptimal performance and potentially affect diagnostic accuracy. Integration with existing systems poses another challenge. New mammography systems need to be compatible with existing healthcare IT infrastructure, including electronic health records (EHRs) and imaging systems. Integration issues can hinder the seamless workflow and data management essential for effective patient care.

Patient comfort and access can be affected by the introduction of advanced technologies. While new systems offer better imaging, they may also require longer procedures or additional steps that impact patient comfort and accessibility.

Category-Wise Acumens

What are the Key Advantages of Full-Field Digital Mammography over Analog Mammography Systems in Breast Cancer Detection?

Full-field mammography segment significantly dominates the mammography systems market. Full-field digital mammography (FFDM) provides significant advantages over Analog Mammography Systems in breast cancer detection. FFDM offers superior image quality with higher resolution and greater detail, enabling better visualization of small or subtle abnormalities. This enhanced clarity improves diagnostic accuracy. FFDM typically requires lower radiation doses, reducing patient exposure while still maintaining effective screening results. The faster image acquisition and processing times associated with digital systems enhance efficiency, reducing the time patients spend in imaging and allowing for quicker diagnosis.

The digital images can be easily manipulated, such as adjusting contrast and brightness, which assists radiologists in detecting and analyzing potential issues more effectively. These benefits collectively make FFDM a more advanced and effective tool for breast cancer detection compared to traditional analog mammography systems.

What Factors Influence the Choice of Mammography Systems in Diagnostic Centers Compared to Hospitals, and how do these Factors Affect their Implementation and Patient Outcomes?

The choice of mammography systems in diagnostic centers compared to hospitals is influenced by various factors affecting their implementation and patient outcomes. Cost and budget constraints often drive diagnostic centers to select cost-effective systems that provide a balance between quality and affordability. In contrast, hospitals with larger budgets might invest in the latest advanced technologies, such as 3D mammography systems, to offer comprehensive services. The volume of patients plays a role; hospitals, managing higher patient loads, may require high-capacity systems for efficiency, while diagnostic centers, which focus on specialized screenings, might choose high-resolution systems for detailed analysis.

Space and infrastructure are also considerations, with diagnostic centers opting for more compact or versatile systems due to limited space, whereas hospitals can accommodate larger systems and integrate them into extensive imaging departments. Finally, diagnostic centers may prioritize state-of-the-art technologies due to their specialization in mammography, while hospitals integrate mammography with a broader range of diagnostic modalities.

What Factors Contribute to North America's Leadership In the Mammography Systems Market, and how do these Factors Influence the Adoption of Advanced Technologies In the Region?

North America significantly dominates the mammography systems and it is expected to maintain throughout the forecast period driven by the United States, the largest economy in North America, which generates the majority of the market's revenue. High healthcare spending in countries like the United States and Canada supports the acquisition of advanced mammography systems and funds comprehensive screening programs. The region's well-established healthcare infrastructure, including state-of-the-art medical facilities, is well-equipped to integrate and utilize advanced technologies such as digital and 3D mammography.

Government initiatives also play a crucial role in robust public health campaigns and policies promoting early breast cancer detection driving demand for advanced systems. North America is a leader in technological innovation, being at the forefront of developing and implementing cutting-edge mammography technologies that enhance diagnostic accuracy and patient outcomes. These factors together ensure that North America remains a global leader in the mammography systems market, influencing both technology adoption and market expansion.

How is the Adoption of Mammography Systems Evolving in the Asia-Pacific Region?

The Asia-Pacific region is anticipated to experience the fastest growth in the mammography systems market during the forecast period driven by rapid economic growth in countries is leading to increased healthcare investment, which supports the procurement of advanced medical technologies, including mammography systems. The expansion of healthcare infrastructure and the development of new healthcare facilities are making sophisticated diagnostic tools more accessible. Government initiatives aimed at improving cancer screening and early detection, particularly in emerging economies, are also driving market growth. Public health campaigns and increased awareness about breast cancer are contributing to higher demand for mammography services.

The partnerships between international companies and local healthcare providers are facilitating the introduction and expansion of advanced mammography technologies in the region. These collaborative efforts help address disparities in access to quality screening services and support the implementation of digital and 3D mammography systems. The Asia-Pacific region is experiencing a notable increase in the adoption of mammography systems, driven by economic development, healthcare expansion, and a growing emphasis on early cancer detection.

Competitive Landscape

The competitive landscape of the Mammography Systems Market is dynamic and constantly evolving. New players are entering the market, and existing players are investing in research and development to maintain their competitive edge. The market is characterized by intense competition, rapid technological advancements, and a growing demand for innovative and efficient solutions.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the mammography systems market include:

  • Philips N.V.
  • General Electric Company
  • Analogic Corporation
  • Carestream Health, Inc.
  • Planmed Oy
  • Delphinus Medical Technologies
  • Fujifilm Holdings Corporation
  • Hologic, Inc.
  • IMS Giotto S.P.A
  • Konica Minolta Inc.

Latest Developments

  • In April 2024, Hologic Inc. has announced its acquisition of Endomag, a breast care company, for $310 million. This acquisition aims to expand Hologic's breast surgery portfolio with Endomag's technologies, including the Magseed marker for magnetic tissue localization, Magtrace injectable for lymphatic tracing in breast cancer staging, and the Sentimag platform. These additions will enhance options for surgeons and radiologists, catering to the specific needs of patients undergoing critical breast cancer procedures.
  • In December 2024, Lunit, a medical AI company, has agreed to acquire Volpara Health Technologies, based in New Zealand and known for its AI-powered software for early detection of breast cancer.

Mammography Systems Market, By Category

  • Product Type:
  • Full-Field Digital Mammography
  • Analog Mammography Systems
  • Breast Tomosynthesis Systems
  • Technology:
  • Screen-Film Mammography
  • Digital Mammography

3D Mammography

  • End-User:
  • Hospitals
  • Diagnostic Centers
  • Specialty Clinics
  • Region:
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL MAMMOGRAPHY SYSTEMS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL MAMMOGRAPHY SYSTEMS OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL MAMMOGRAPHY SYSTEMS MARKET, BY TECHNOLOGY

  • 5.1 Overview
  • 5.2 Screen-Film Mammography
  • 5.3 Digital Mammography
  • 5.4 3D Mammography

6 GLOBAL MAMMOGRAPHY SYSTEMS MARKET, BY PRODUCT TYPE

  • 6.1 Overview
  • 6.2 Full-Field Digital Mammography
  • 6.3 Analog Mammography Systems
  • 6.4 Breast Tomosynthesis Systems

7 GLOBAL MAMMOGRAPHY SYSTEMS MARKET, BY END USER

  • 7.1 Overview
  • 7.2 Hospitals
  • 7.3 Diagnostic Centers
  • 7.4 Specialty Clinics

8 GLOBAL MAMMOGRAPHY SYSTEMS MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East and Africa

9 GLOBAL MAMMOGRAPHY SYSTEMS MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Philips N.V
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 General Electric Company
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Analogic Corporation
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Carestream Health Inc.
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Fujifilm Holdings Corporation
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Delphinus Medical Technologies
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Hologic Inc
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Planmed Oy
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 IMS Giotto S.P.A
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 Konica Minolta Inc
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 Appendix

  • 11.1 Related Research